Xeltis: Funding, Investors & Team (Sep 2026)
The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis. When colonised by the patient's own tissue cells, Xeltis devices naturally transform into living blood arteries or heart valves. wwwxeltiscom
Xeltis has raised $72.7M across 3 funding rounds on record, the most recent an undisclosed round of $23.3M announced in Jul 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Xeltis Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Xeltis Funding Rounds
Xeltis raised $15.3M in a Series D announced in Aug 2022.
6 months later, a Series D of $34.1M was announced in Feb 2023.
3.4 years later, an undisclosed round of $23.3M was announced in Jul 2026.
Xeltis Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Xeltis Founders and Leadership Team
Contact details for the Xeltis team: 2 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Xeltis Funding Compared to Other Health Care Startups
Xeltis' latest round of $23.3M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Xeltis in Health Care and Eindhoven
Companies Similar to Xeltis
Vitestro revolutionizes the way patients are cared for by introducing independent blood-drawing technology.
ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and…
Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have…
CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left…
Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in…
Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a…
Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current…
AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines…
Sirius medical helps in improving healthcare for cancer patients by developing medical devices that helps in…
PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health…
Vico Therapeutics specializes in creating RNA-modulating treatments for rare neurological conditions. The…
Xeltis Funding FAQs
What does Xeltis do?
The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis. When colonised by the patient's own tissue cells, Xeltis devices naturally transform into living blood arteries or heart valves. wwwxeltiscom
How much funding has Xeltis raised?
Xeltis has raised $72.7M across 3 rounds on record. The most recent is an undisclosed round of $23.3M announced in Jul 2026.
When did Xeltis last raise funding?
Xeltis' most recent funding round on record is an undisclosed round of $23.3M, announced in Jul 2026.
Who has invested in Xeltis?
Investors on record for Xeltis include European Investment Bank, Invest-NL, European Innovation Council, EQT Life Sciences, Ysios Capital. FundedIQ records 11 investors in total.
Who is the CEO of Xeltis?
Eliane Schutte is listed as CEO at Xeltis.
Where is Xeltis headquartered?
Xeltis is based in Eindhoven, Noord-Brabant, Netherlands.
How many employees does Xeltis have?
Xeltis is in the 11-50 employee band.
When was Xeltis founded?
Xeltis was founded in 2006.
How does Xeltis' funding compare to other Health Care startups?
Xeltis' latest round of $23.3M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Xeltis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xeltis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.